M Brankin, (@brankinm) profile picture

Interested in all things stock market.Any mention of stocks is NOT Investment advice or recommendation. Assume any stocks mentioned I hold. DYOR.

Joined June 2016
Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)Photo by M Brankin, (@brankinm)
#USNSComfort Arriving in New York. Some hope in these difficult times. Stay safe.
4
5
16
Tokio Marine H1: adj NI guide nudged to ¥970bn but benign cats + equity sales did the lifting while auto claims, Greensill & the Middle East pushed back Real tell an extra ¥80bn of buybacks. Capital going back to holders not to Suncorp. Fair value ~¥565. Price ¥566. Shrug $TKOMY
20
$JPM in a note led by chief US economist Michael Feroli. It’s a hiking cycle, not a single move: sees hikes at next 3 Fed meetings. It may happen, it may not but this is the perception and environment the market is in. Just saying.
19
$PANW Q1 beat everywhere ARR +66% to $9.73bn FY27 guide raised ~3x the revenue beat plus a $4.5bn all stock AI deal Catch GAAP profit came from tax credit, stock comp 18% of sales and trades at 87x this year EPS after+20% 1 day +AH move. Great quarter at a price already paid for
1
45
Hungary kills the Orbán-era tobacco wholesale monopoly from Jun-27. $BTI owns part of ODBE, but its share of ~£25m profit is <0.1% of group EBIT. Manufacturers can now deliver direct, which could even be a small positive. Pécs pouch hub untouched. Headline noise 🇭🇺🚬
86
$VIK Q3 rivers ran dry EPS $1.11 vs $1.27. Strip the ~$100m water hit and it’s ~$1.33 a beat Real news 2027 yield goal trimmed to low-to-mid single digit on $265m goodwill vouchers and Q4 cancels running 20%. Ocean 77% booked at +11% Weather or climate? 22x ‘27 says weather
32
#IMB FY26: beat on EPS (341p vs 334p), FY27 guide above cons (~3.7% vs 2.9% op growth), £1.5bn buyback, 5.7% yield but Europe vols -7.8%, German excise cliff, FX drag, FCF floor cut to £2.2bn 8x P/E, ~12% shareholder yield. Paid to wait, not paid to dream. 🚬📉📈
1
35
Most boring company in my consumer sleeve..somethimes boring is good
9
#LGEN Q3: solvency 213% (+12pts) Workplace flows £4.5bn in a quarter EPS guide above 9% reaffirmed Market sells as PRT 20% light and Asset Man found £2m of new revenue down the sofa. The engine is fine the shop window is thin 7% yield, 7% buyback, priced for exactly that
2
48
$ANET and $GEV remain among the cheapest Morningstar-covered stocks after strong earnings beats. Here’s a closer look at 7 undervalued stocks that crushed this quarter’s earnings and revenue expectations. spr.ly/6014ByKafj
5
24
3
184
28,377
$AV.L Q3: premiums +19% Wealth flows +31%, solvency up. All guidance reiterated Soft spots: Canada cats, thinner annuity margins, £350m Direct Line capital synergy still pending. Good results, but the share price already reflects them at ~11x earnings. Hold for the 6% yield.
1
3
51
But what do I know 😉 #AV share price ⬆️ 3.41%
1
36
$MUFG 1H: ¥1.63tn NI (+26%), FY guide → ¥2.8tn DPS ¥100 Margins + Morgan Stanley doing the heavy lifting; credit costs barely touched. But a ¥200bn buyback < SMFG’s ¥220bn and payout slips to 51%. Earnings 🟢 capital return 🟡. Guide is sandbagged
41
#KLR Keller update: in line, no raise. FY26 UOP £242m unchanged, order book c.£2.5bn (£1.9bn Jun) £80m of £100m buyback done. Street FY27 rev growth 5% = floor of the 5-7% CMD target. 3,090p, -1% (dipped 9%, bought), +85% YTD, 12.5x P/E.
17
Chemring #CHG FY26: £79m EBIT vs £80.3m cons - a rounding error punished like a profit warning −3%. Record £1.4bn book, net debt £29m better (capex timing don’t get excited) US Sensors for sale. Roke still waiting on the MOD. 21x FY27 for +27% growth. The real test is 8 Dec
42
#MKS CMD - doubled divi to 8.4p, reaffirmed £600m cost-out, MSD-HSD sales growth Fine print: Food margin target “~5%” vs 5.6% delivered in H1 and ~5.8–5.9% consensus FH&B >10% just matches Street Stock at a 10-yr high on ~13x. The dividend got the cheers. Watching food margin
35
$WRBY +22% pre market on a quarter that matched consensus. Revenue in line, EBITDA beat, guide midpoint up a smidge Active customers +3% (was +9%). Margins helped by tariff refunds won’t repeat Rally is about Gemini glasses pre-orders 12 Nov. The 2027 cost bill comes later 👓
1
127
$WRBY +20% intraday. +45% in 3 sessions on a quarter that matched consensus. Short interest was ~20% of float on 10/15. Citizens just set a $40 Street-high target, and glasses preorders open Thursday. Shorts covering ahead of a product nobody has priced yet?
1
1
133
$CEG Q3: $5.06 vs $3.89 est. Guide raised again to $12.50–12.80. Amazon + Google sign 20-yr nuclear. But my simple maths: implied Q4 ~$2.30 vs $3.10 Street. Part of this beat was borrowed from December. ~20x fwd, half its 2025 peak. Contracts real. Texas politics too.
53
$TAP Q3: EPS on the nose, guidance in the bin FY26 EPS now -16% to -19%, FCF cut to $1bn leverage up to 2.5x still buying back stock US brand volume -5.6% Best part of the business is bit they rent from #FEVR US$ sales +13% and not even a mention. 9x P/E is cheap for a reason
1
112
$TAP downgrade from $JPM to underweight citing weakness in beer and cost inflation. I'd suggest they need to expand non alcoholic brand offering...#FEVR but.....
1
84
#FEVR takeover thesis just got a hangover $TAP spent $275m cash on Monaco cocktails, cut FY guidance and leverage up to 2.5x Seem to prefer cheap brands they can own outright They get FeverTree US growth via royalty deal at fraction of price Partnership: working. Bid: 🤷🍸
33